GLAXOSMITHKLINE PLC

GSK
Real-time Estimate Quote. Real-time Estimate  - 08/07 11:30:00 am
1554.1GBX +0.26%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 33 75435 121
EBITDA1 11 96810 436
Operating profit (EBIT)1 8 9729 089
Operating Margin 26,6%25,9%
Pre-Tax Profit (EBT)1 6 2217 148
Net income1 4 6454 615
Net margin 13,8%13,1%
EPS2 0,931,00
Dividend per Share2 0,800,80
Last update 02/05/202008/05/2020
1 GBP in Million
2 GBP
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 25 72223 344
Net Cash position1 --
Leverage (Debt / EBITDA) 2,15x2,24x
Free Cash Flow1 5 0736 212
ROE (Net Profit / Equities) 75,0%47,4%
Shareholders' equity1 6 1919 742
ROA (Net Profit / Asset) 8,90%5,00%
Assets1 52 18592 298
Book Value Per Share2 2,423,81
Cash Flow per Share2 1,601,40
Capex1 1 2651 509
Capex / Sales 3,75%4,30%
Last update 02/05/202008/05/2020
1 GBP in Million
2 GBP
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 77 400 M GBP -
Entreprise Value (EV) 100 744 M GBP 98 605 M GBP
Valuation 2020e 2021e
P/E ratio (Price / EPS) 15,6x 17,6x
Capitalization / Revenue 2,20x 2,14x
EV / Revenue 2,87x 2,78x
EV / EBITDA 9,65x 8,91x
Yield (DPS / Price) 5,14% 5,15%
Price to book (Price / BVPS) 4,08x 5,42x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 25,9% 26,0%
Operating Leverage (Delta EBIT / Delta Sales) 0,32x 1,10x
Net Margin (Net Profit / Revenue) 13,1% 12,1%
ROA (Net Profit / Asset) 5,00% 6,41%
ROE (Net Profit / Equities) 47,4% 45,9%
Rate of Dividend 80,1% 90,6%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   4,30% 4,10%
Cash Flow / Sales 19,8% 21,5%
Capital Intensity (Assets / Sales) 2,63x 1,89x
Financial Leverage (Net Debt / EBITDA) 2,24x 1,88x
Price Earning Ratio
EPS & Dividend